Oncology

Stereotactic ablative radiation therapy shows promise in treating extracranial sarcoma metastases

Stereotactic ablative radiation therapy (SABR) shows promise in treating extracranial sarcoma metastases, according to a study that suggests that age and the distinction between lung and non-lung metastases are important prognostic factors for overall survival (OS). The study identified a total of 94 patients with 118 lesions, predominantly located in...